Cargando…

Selected ideal natural ligand against TNBC by inhibiting CDC20, using bioinformatics and molecular biology

Object: Find potential therapeutic targets of triple-negative breast cancer (TNBC) patients by bioinformatics. Screen ideal natural ligand that can bind with the potential target and inhibit it by using molecular biology. Methods: Bioinformatics and molecular biology were combined to analyze potenti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Naimeng, Wang, Xinhui, Zhu, Zhu, Li, Duo, Lv, Xiaye, Chen, Yichang, Xie, Haoqun, Guo, Zhen, Song, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580355/ https://www.ncbi.nlm.nih.gov/pubmed/34686627 http://dx.doi.org/10.18632/aging.203642

Ejemplares similares

Computational study of effective matrix metalloproteinase 9 (MMP9) targeting natural inhibitors
por: Liu, Naimeng, et al.
Publicado: (2021)

Identification of effective natural PIK3CA H1047R inhibitors by computational study
por: Liu, Naimeng, et al.
Publicado: (2021)

Novel natural inhibitors targeting B-RAF(V600E) by computational study
por: Wu, Bo, et al.
Publicado: (2021)

Computational study on novel natural inhibitors targeting BCL2
por: Lv, Xiaye, et al.
Publicado: (2021)

Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma
por: Sungwan, Prin, et al.
Publicado: (2021)

Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis
por: Ji, Ping, et al.
Publicado: (2016)

MiR-27a Modulates Radiosensitivity of Triple-Negative Breast Cancer (TNBC) Cells by Targeting CDC27
por: Ren, Yong-qiang, et al.
Publicado: (2015)

Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Androgen Receptor-Positive TNBC
por: Guo, Qiaonan, et al.
Publicado: (2022)

Chemotherapy with ceramide in TNBC
por: Legembre, Patrick, et al.
Publicado: (2015)

GHRH-antagonists in TNBC
por: Engel, Jörg B.
Publicado: (2015)

Cripto-1 in TNBC
por: Castro, Nadia P, et al.
Publicado: (2015)

Doing the CDC20 shuffle
por: Wells, William A.
Publicado: (2003)

Selected using bioinformatics and molecular docking analyses, PHA-793887 is effective against osteosarcoma
por: Wu, Bo, et al.
Publicado: (2021)

The Landscape of Targeted Therapies in TNBC
por: Vagia, Elena, et al.
Publicado: (2020)

Neural Functions Play Different Roles in Triple Negative Breast Cancer (TNBC) and non-TNBC
por: Tan, Renbo, et al.
Publicado: (2020)

Identification of novel natural inhibitors targeting AKT Serine/Threonine Kinase 1 (AKT1) by computational study
por: Zhong, Sheng, et al.
Publicado: (2022)

An Magnetic-Targeting Nano-Diagnosis and Treatment Platform for TNBC
por: Zhang, Mengqi, et al.
Publicado: (2023)

Regulation of APC/C(Cdc20) activity by RASSF1A–APC/C(Cdc20) circuitry
por: Chow, C, et al.
Publicado: (2012)

BCAP31 drives TNBC development by modulating ligand-independent EGFR trafficking and spontaneous EGFR phosphorylation
por: Fu, Wenyan, et al.
Publicado: (2019)

Cdh1 Deficiency Sensitizes TNBC Cells to PARP Inhibitors
por: Li, Junjun, et al.
Publicado: (2022)

The Evaluation of Cytotoxic Properties from CCB-2 Sugar Complexes Against TNBC and Non-TNBC Cells
por: Jenie, Riris Istighfari, et al.
Publicado: (2021)

Biological Collections: Chasing the Ideal
por: Kamenski, P. A., et al.
Publicado: (2016)

TNBC invasion: downstream of STAT3
por: Jackson, James G., et al.
Publicado: (2017)

CDC20 inhibitor Apcin inhibits embryo implantation in vivo and in vitro
por: Guo, Chuanjia, et al.
Publicado: (2020)

CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis
por: Li, Jianxin, et al.
Publicado: (2020)

The bioinformatics and experimental analysis of the novel roles of virus infection-associated gene CDC20 for prognosis and immune infiltration in hepatocellular carcinoma
por: Li, Juanni, et al.
Publicado: (2022)

Phosphorylation by Cdc28 Activates the Cdc20-Dependent Activity of the Anaphase-Promoting Complex
por: Rudner, Adam D., et al.
Publicado: (2000)

Biological and Pathological Implications of an Alternative ATP-Powered Proteasomal Assembly With Cdc48 and the 20S Peptidase
por: Esaki, Masatoshi, et al.
Publicado: (2018)

Regulated degradation of the APC coactivator Cdc20
por: Robbins, Jonathan A, et al.
Publicado: (2010)

CDC20 maintains tumor initiating cells
por: Xie, Qi, et al.
Publicado: (2015)

Computational study on novel natural inhibitors targeting c-MET
por: Hou, Yuanyuan, et al.
Publicado: (2021)

The Potential of PSMA as a Vascular Target in TNBC
por: Heesch, Amelie, et al.
Publicado: (2023)

Aptamer-Based Strategies to Boost Immunotherapy in TNBC
por: Agnello, Lisa, et al.
Publicado: (2023)

Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
por: Chaudhuri, Aiswarya, et al.
Publicado: (2023)

Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro
por: Choi, Hoon Sik, et al.
Publicado: (2021)

Fission Yeast Apc15 Stabilizes MCC-Cdc20-APC/C Complexes, Ensuring Efficient Cdc20 Ubiquitination and Checkpoint Arrest
por: May, Karen M., et al.
Publicado: (2017)

Baicalein enhances immune response in TNBC by inhibiting leptin expression of adipocytes
por: Liu, Mengjie, et al.
Publicado: (2023)

Comparisons of Oncologic Outcomes between Triple-Negative Breast Cancer (TNBC) and Non-TNBC among Patients Treated with Breast-Conserving Therapy
por: Kim, Sanghwa, et al.
Publicado: (2016)

Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target
por: Koni, Malvina, et al.
Publicado: (2022)

LC–MS Based Lipidomics Depict Phosphatidylethanolamine as Biomarkers of TNBC MDA-MB-231 over nTNBC MCF-7 Cells
por: Estrada-Pérez, Alan Rubén, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s0usafd7jjdfsu04gvf1vkeijn